Iridogoniodysgenesis, dominant type

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Iridogoniodysgenesis, dominant type | |
|---|---|
| Synonyms | |
| Pronounce | |
| Specialty | Ophthalmology |
| Symptoms | Iris abnormalities, glaucoma |
| Complications | Vision loss, blindness |
| Onset | Congenital |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | Other anterior segment dysgenesis disorders |
| Prevention | Genetic counseling |
| Treatment | Glaucoma surgery, medication |
| Medication | Topical beta-blockers, prostaglandin analogs |
| Prognosis | Variable, depends on severity of glaucoma |
| Frequency | Rare |
| Deaths | N/A |
Iridogoniodysgenesis, dominant type is a rare genetic disorder that affects the development of the iris and the anterior chamber of the eye. This condition is characterized by abnormalities in the iris and the trabecular meshwork, which can lead to glaucoma and other ocular complications.
Clinical Features[edit]
Individuals with iridogoniodysgenesis, dominant type, typically present with distinctive ocular features, including:
- Iris hypoplasia: Underdevelopment of the iris.
- Corectopia: Displacement of the pupil.
- Ectropion uveae: The presence of uveal tissue on the surface of the iris.
- Anterior segment dysgenesis: Abnormal development of the structures in the front part of the eye.
Genetics[edit]
Iridogoniodysgenesis, dominant type, is inherited in an autosomal dominant manner. This means that a single copy of the altered gene in each cell is sufficient to cause the disorder. The specific gene or genes involved in this condition are not yet fully understood, but it is known to be associated with mutations in genes that play a role in the development of the anterior chamber of the eye.
Diagnosis[edit]
The diagnosis of iridogoniodysgenesis, dominant type, is based on clinical examination and the identification of characteristic ocular features. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the condition.
Management[edit]
Management of iridogoniodysgenesis, dominant type, focuses on monitoring and treating glaucoma and other ocular complications. This may include:
- Regular ophthalmologic examinations to monitor intraocular pressure and the health of the optic nerve.
- Medications to lower intraocular pressure.
- Surgical interventions, such as trabeculectomy or glaucoma drainage devices, to manage glaucoma.
Prognosis[edit]
The prognosis for individuals with iridogoniodysgenesis, dominant type, varies depending on the severity of the condition and the effectiveness of glaucoma management. Early diagnosis and appropriate treatment are crucial in preventing vision loss and other complications.
See also[edit]
- Iris hypoplasia
- Corectopia
- Ectropion uveae
- Anterior segment dysgenesis
- Glaucoma
- Autosomal dominant
- Genetic testing
- Trabeculectomy
- Glaucoma drainage devices
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
